Rilapladib (SB 659032) (SB 659032) 是一种选择性 Lp-PLA2(脂蛋白相关磷脂酶 A2)抑制剂,IC50 为 230 pM。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Rilapladib is a selective Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) inhibitor with an IC50 of 230 pM.
[1]. Shaddinger BC, et al. Platelet aggregation unchanged by lipoprotein-associated phospholipase A? inhibition: results from an in vitro study and two randomized phase I trials. PLoS One. 2014 Jan 27;9(1):e83094.
LX1606 Hippurate (Telotristat etiprate)
¥580.00 ¥725.00
没有评价数据